User:Lois A. Fridmann/Sandbox 3
From Proteopedia
(Difference between revisions)
(New page: =Green Fluorescent Protein Mutant F99S/M153T/V163A - c3-GFP= description '''Three mutations on the beta barrel of the Green Fluorescent P...) |
|||
Line 1: | Line 1: | ||
- | = | + | =Tsg101 UEV Domain - Residue Mutations in the C-Terminal End= |
- | + | ||
- | + | ||
__TOC__ | __TOC__ | ||
- | ==Background== | + | ==Background and History of HIV== |
- | Wild type [[Green Fluorescent Protein]] (wtGFP) was acquired from the luminescent ''Aequorea victoria'' jellyfish. It is a 238 amino acid protein and the fluorescent chromophore is formed by internal cyclization of a Serine-Tyrosine-Glycine tripeptide. Wild type GFP absorbs blue light primarily at 395 nm accompanied by a smaller peak at 475 nm and emits green light at 509 nm with a smaller peak at 540 nm. The Green Fluorescent Protein has been used as a reporter protein for gene expression, protein localization and cell linage information. The slow rate of fluorescence attainment in vivo limits the GFP as a reporter for gene expression. Considerable variations of GFP have been created in order to help determine the structure and function of the wtGFP. These mutations have been made in order to enhance the use of GFP as a reporter of gene regulation and expression, protein transport, and heredity. GFP has been mutated to provide an increased or alternative color for fluorescence, for a greater time period and to make it less susceptible to photo bleaching. The specific GFP mutation featured is referred to as Mutant F99S/M153T/V163A or cycle 3 GFP (c3-GFP). | ||
- | + | ||
- | + | (Generalized to other viruses: A large number of viruses in other families conserve the PTAP binding site, conserving something that is affective for other viruses) | |
+ | |||
+ | |||
+ | ==Structural Details of C-terminal mutant Tsg101== | ||
+ | |||
==Chemical Properties== | ==Chemical Properties== | ||
- | The overall characteristic of the c3-GFP closely resemble the wtGFP, however due to the three mutations it is 42-fold more fluorescent in vivo compared to wtGFP. This phenomenon arises because the replacement of the hydrophobic amino acids with hydrophilic or less hydrophobic amino acids causes less aggregation and results in improved autocatalytic activation of the chromophore. The reduction in the hydrophobic nature on the surface of the c3-GFP also results in an increased ability of the mutant to mature in vivo effectively at 37 degrees Celsius. This is a feature the wtGFP lacks because the A. victoria jellyfish in the Pacific Northwest, from which it was first extracted, had never experienced such high temperatures. Thus the wtGFP has its limitations as a gene expression marker. The c3-GFP mutant is unique because unlike most mutants, the structure of the chromophore and the fluorescence spectrum remains the same as the wtGFP. The enhanced c3-GFP provides for a better tool for researchers as compared with the wtGFP. | ||
- | ==References== | ||
- | 1. Battistutta R, Negro A, Zanotti G. 2000. Crystal Structure and Refolding Properties of the Mutant F99S/M153T/V163A of the Green Fluorescent Protein. Proteins: Structure, Function, and Genetics 41:429 – 437. | ||
- | + | ==Additional Mutations== | |
- | 3. Fukuda H, Arai M, Kuwajima K. 2000. Folding of Green Fluorescent Protein and the Cycle3 Mutant. Biochemistry 39:12025 – 12032. | ||
- | + | ==Contributions to Future Research and Therapies== | |
- | ==External Links== | ||
- | http://www.conncoll.edu/ccacad/zimmer/GFP-ww/GFP-1.htm | ||
- | + | ==References== | |
+ | 1. | ||
- | + | 2. | |
+ | |||
+ | 3. | ||
+ | |||
+ | 4. | ||
+ | |||
+ | ==External Links== |
Revision as of 13:25, 2 April 2009
Tsg101 UEV Domain - Residue Mutations in the C-Terminal End
Contents |
Background and History of HIV
(Generalized to other viruses: A large number of viruses in other families conserve the PTAP binding site, conserving something that is affective for other viruses)
Structural Details of C-terminal mutant Tsg101
Chemical Properties
Additional Mutations
Contributions to Future Research and Therapies
References
1.
2.
3.
4.